• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉络膜视网膜母细胞瘤治疗后出现苯丙氨酸毒性的图形视网膜电图表现。

Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram.

机构信息

Department of Pediatric Ophthalmology and Strabismus and Adult Motilty, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA.

School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Ophthalmic Genet. 2023 Aug;44(4):385-388. doi: 10.1080/13816810.2022.2116652. Epub 2022 Nov 4.

DOI:10.1080/13816810.2022.2116652
PMID:36330605
Abstract

PURPOSE

To describe a patient with retinoblastoma and subsequent maculopathy unrelated to the tumor but related to intra-arterial melphalan documented by pattern electroretinography.

METHODS

Comprehensive ophthalmic evaluation, treatment with intra-arterial chemotherapy and subsequent follow-up including electroretinography to assess for macular dysfunction.

RESULTS

A 3-year-old child was evaluated with electrophysiological investigations following treatment of unilateral Group D retinoblastoma with intra-arterial and intravitreal chemotherapy with melphalan. Pattern reversal visual evoked potential amplitude and P100 latency were normal in the left eye, but abnormal and delayed in the right eye. Pattern electroretinograms (pERGs) were abnormal on the right eye. Flash electroretinograms (fERGs) were normal on both eyes. Visual acuity dysfunction of 20/50 attributed to melphalan was seen on the right eye vs 20/40 on the left eye.

CONCLUSION

Our case report demonstrates that pERG rather than fERG should be used to monitor baseline macular function and potential toxicity in children undergoing chemotherapy for retinoblastoma using skin electrodes when corneal electrodes are not tolerated.

摘要

目的

描述一名患有视网膜母细胞瘤(RB)且与肿瘤无关但与动脉内注射甲氨蝶呤(melphalan)相关的黄斑病变患者,该病变可通过图形视网膜电图(pattern electroretinography)记录。

方法

全面眼科评估、接受动脉内化疗治疗,以及后续进行视网膜电图检查以评估黄斑功能。

结果

一名 3 岁儿童在接受单侧 D 组 RB 治疗后,进行了包括电生理研究在内的综合评估,该治疗采用了动脉内和玻璃体内注射甲氨蝶呤。左眼的图形翻转视觉诱发电位(pattern reversal visual evoked potential)振幅和 P100 潜伏期正常,但右眼异常且延迟。右眼图形视网膜电图(pattern electroretinogram,pERG)异常。双眼闪光视网膜电图(flash electroretinogram,fERG)正常。右眼视力障碍为 20/50,归因于甲氨蝶呤,而左眼为 20/40。

结论

我们的病例报告表明,当角膜电极不能耐受时,在接受化疗治疗 RB 的儿童中,使用皮肤电极进行监测时,pERG 而不是 fERG 应该用于监测基线黄斑功能和潜在毒性。

相似文献

1
Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram.脉络膜视网膜母细胞瘤治疗后出现苯丙氨酸毒性的图形视网膜电图表现。
Ophthalmic Genet. 2023 Aug;44(4):385-388. doi: 10.1080/13816810.2022.2116652. Epub 2022 Nov 4.
2
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.一项关于美法仑经动脉(眼动脉)直接化疗用于眼内视网膜母细胞瘤的I/II期研究:初步结果
Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.
3
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).超选择性眼动脉化疗作为视网膜母细胞瘤(化疗手术)的主要治疗方法。
Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.
4
Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.眼内动脉注射氨甲蝶呤治疗难治性视网膜母细胞瘤和符合年龄的视力患者的视力结果。
Br J Ophthalmol. 2013 Nov;97(11):1464-70. doi: 10.1136/bjophthalmol-2013-303694. Epub 2013 Sep 13.
5
Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.降低难治性视网膜母细胞瘤动脉内化疗(IAC)后严重视力丧失和并发症的发生率。
Br J Ophthalmol. 2017 Dec;101(12):1704-1708. doi: 10.1136/bjophthalmol-2017-310294. Epub 2017 Apr 21.
6
Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.原发性动脉内化疗控制视网膜母细胞瘤:玻璃体内化疗时代之前及期间的结果
J Pediatr Ophthalmol Strabismus. 2016 Sep 1;53(5):275-84. doi: 10.3928/01913913-20160719-04. Epub 2016 Aug 4.
7
Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.眼内动脉化疗治疗视网膜母细胞瘤的首例小动物(兔)模型的药代动力学、组织定位、毒性和疗效。
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):446-454. doi: 10.1167/iovs.17-22302.
8
Complete regression of retinoblastoma following intra-arterial chemotherapy.动脉内化疗后视网膜母细胞瘤完全消退。
J Pediatr Ophthalmol Strabismus. 2011 Jun 7;48 Online:e23-5. doi: 10.3928/01913913-20110531-02.
9
Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.玻璃体内注射美法仑治疗视网膜母细胞瘤后视网膜功能的持久性
Doc Ophthalmol. 2013 Feb;126(1):79-84. doi: 10.1007/s10633-012-9358-6. Epub 2012 Nov 11.
10
Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.眼内动脉注射马法兰治疗视网膜母细胞瘤后发生急性脉络膜缺血的危险因素:导管入路的作用。
Ophthalmology. 2021 May;128(5):754-764. doi: 10.1016/j.ophtha.2020.09.021. Epub 2020 Sep 19.

引用本文的文献

1
Electroretinographic changes in the inner and outer retinal layers before and after intravenous chemotherapy for retinoblastoma.静脉化疗治疗视网膜母细胞瘤前后内层和外层视网膜的视网膜电图变化。
Indian J Ophthalmol. 2024 Aug 1;72(8):1168-1174. doi: 10.4103/IJO.IJO_2722_23. Epub 2024 Jul 29.